Phase II Trial of Weekly Gemcitabine and Herceptin in the Treatment of Patients With HER-2 Overexpressing Metastatic Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 25 Nov 2014
At a glance
- Drugs Gemcitabine (Primary) ; Trastuzumab (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 11 Mar 2014 Primary endpoint has been changed from safety to efficacy.
- 02 May 2011 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
- 15 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.